Cargando…
Immunodeficiency in Bloom’s Syndrome
Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742600/ https://www.ncbi.nlm.nih.gov/pubmed/29098565 http://dx.doi.org/10.1007/s10875-017-0454-y |
_version_ | 1783288406891036672 |
---|---|
author | Schoenaker, Michiel H. D. Henriet, Stefanie S. Zonderland, Jip van Deuren, Marcel Pan-Hammarström, Qiang Posthumus-van Sluijs, Sandra J. Pico-Knijnenburg, Ingrid Weemaes, Corry M. R. IJspeert, Hanna |
author_facet | Schoenaker, Michiel H. D. Henriet, Stefanie S. Zonderland, Jip van Deuren, Marcel Pan-Hammarström, Qiang Posthumus-van Sluijs, Sandra J. Pico-Knijnenburg, Ingrid Weemaes, Corry M. R. IJspeert, Hanna |
author_sort | Schoenaker, Michiel H. D. |
collection | PubMed |
description | Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair, we aimed to study if BLM deficiency affects T and B cell development and especially somatic hypermutation (SHM) and class switch recombination (CSR) processes. Clinical data of six BS patients was collected, and immunoglobulin serum levels were measured at different time points. In addition, we performed immune phenotyping of the B and T cells and analyzed the SHM and CSR in detail by analyzing IGHA and IGHG transcripts using next-generation sequencing. The serum immunoglobulin levels were relatively low, and patients had an increased number of infections. The absolute number of T, B, and NK cells were low but still in the normal range. Remarkably, all BS patients studied had a high percentage (20–80%) of CD4+ and CD8+ effector memory T cells. The process of SHM seems normal; however, the Ig subclass distribution was not normal, since the BS patients had more IGHG1 and IGHG3 transcripts. In conclusion, BS patients have low number of lymphocytes, but the immunodeficiency seems relatively mild since they have no severe or opportunistic infections. Most changes in the B cell development were seen in the CSR process; however, further studies are necessary to elucidate the exact role of BLM in CSR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-017-0454-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5742600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-57426002018-01-04 Immunodeficiency in Bloom’s Syndrome Schoenaker, Michiel H. D. Henriet, Stefanie S. Zonderland, Jip van Deuren, Marcel Pan-Hammarström, Qiang Posthumus-van Sluijs, Sandra J. Pico-Knijnenburg, Ingrid Weemaes, Corry M. R. IJspeert, Hanna J Clin Immunol Original Article Bloom’s syndrome (BS) is an autosomal recessive disease, caused by mutations in the BLM gene. This gene codes for BLM protein, which is a helicase involved in DNA repair. DNA repair is especially important for the development and maturation of the T and B cells. Since BLM is involved in DNA repair, we aimed to study if BLM deficiency affects T and B cell development and especially somatic hypermutation (SHM) and class switch recombination (CSR) processes. Clinical data of six BS patients was collected, and immunoglobulin serum levels were measured at different time points. In addition, we performed immune phenotyping of the B and T cells and analyzed the SHM and CSR in detail by analyzing IGHA and IGHG transcripts using next-generation sequencing. The serum immunoglobulin levels were relatively low, and patients had an increased number of infections. The absolute number of T, B, and NK cells were low but still in the normal range. Remarkably, all BS patients studied had a high percentage (20–80%) of CD4+ and CD8+ effector memory T cells. The process of SHM seems normal; however, the Ig subclass distribution was not normal, since the BS patients had more IGHG1 and IGHG3 transcripts. In conclusion, BS patients have low number of lymphocytes, but the immunodeficiency seems relatively mild since they have no severe or opportunistic infections. Most changes in the B cell development were seen in the CSR process; however, further studies are necessary to elucidate the exact role of BLM in CSR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10875-017-0454-y) contains supplementary material, which is available to authorized users. Springer US 2017-11-02 2018 /pmc/articles/PMC5742600/ /pubmed/29098565 http://dx.doi.org/10.1007/s10875-017-0454-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Schoenaker, Michiel H. D. Henriet, Stefanie S. Zonderland, Jip van Deuren, Marcel Pan-Hammarström, Qiang Posthumus-van Sluijs, Sandra J. Pico-Knijnenburg, Ingrid Weemaes, Corry M. R. IJspeert, Hanna Immunodeficiency in Bloom’s Syndrome |
title | Immunodeficiency in Bloom’s Syndrome |
title_full | Immunodeficiency in Bloom’s Syndrome |
title_fullStr | Immunodeficiency in Bloom’s Syndrome |
title_full_unstemmed | Immunodeficiency in Bloom’s Syndrome |
title_short | Immunodeficiency in Bloom’s Syndrome |
title_sort | immunodeficiency in bloom’s syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742600/ https://www.ncbi.nlm.nih.gov/pubmed/29098565 http://dx.doi.org/10.1007/s10875-017-0454-y |
work_keys_str_mv | AT schoenakermichielhd immunodeficiencyinbloomssyndrome AT henrietstefanies immunodeficiencyinbloomssyndrome AT zonderlandjip immunodeficiencyinbloomssyndrome AT vandeurenmarcel immunodeficiencyinbloomssyndrome AT panhammarstromqiang immunodeficiencyinbloomssyndrome AT posthumusvansluijssandraj immunodeficiencyinbloomssyndrome AT picoknijnenburgingrid immunodeficiencyinbloomssyndrome AT weemaescorrymr immunodeficiencyinbloomssyndrome AT ijspeerthanna immunodeficiencyinbloomssyndrome |